AngioDynamics | ANGO - Sales Revenues

Stock Price
10.44
Daily Change
-0.03 -0.29%
Monthly
-2.16%
Yearly
10.36%
Q2 Forecast
9.53

AngioDynamics reported $79.43M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 140.5M 6.2M Dec/2025
Boston Scientific USD 5.29B 220M Dec/2025
Edwards Lifesciences USD 1.57B 20M Dec/2025
ICU Medical USD 540.7M 3.7M Dec/2025
Inogen USD 74.93M 504K Sep/2024
J&J USD 24.1B 500M Mar/2026
Medtronic USD 9B 39M Jan/2026
Merit Medical Systems USD 393.9M 9.7M Dec/2025
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 219.91M 14.28M Dec/2025
Smiths GBP 1.44B 133M Jan/2026
Surmodics USD 29.57M 355K Jun/2025
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Terumo JPY 296.63B 21.66B Dec/2025
Trinity Biotech USD 14.31M 1.55M Sep/2025